For carefully selected mental-health patients

Ketamine-Assisted Care

The clearest evidence is for treatment-resistant depression—depression that has not improved enough after standard treatment. Ketamine is not a casual wellness treatment and it is not appropriate for everyone.

Does this sound familiar?

Start with what you are actually feeling.

These signs do not diagnose the problem by themselves, but they can be a good reason to have a medical conversation.

YOU MAY NOTICE

Depression will not lift

YOU MAY NOTICE

Nothing feels enjoyable

YOU MAY NOTICE

No motivation or energy

YOU MAY NOTICE

Daily life feels very hard

What this service is

A medically supervised option for selected patients whose depression has not responded well enough to standard care.

Ketamine works differently from standard antidepressants and may reduce depressive symptoms more quickly in some patients. Intravenous ketamine for depression is an off-label use; FDA-approved esketamine is a related treatment delivered as a nasal spray in certified clinical settings. Evaluation, monitoring and follow-up are essential.

How it works

Simple steps, medically supervised.

STEP 1

Confirm the clinical picture

We review diagnosis, past treatments, medications, substance-use history, medical risks and whether ketamine is a reasonable option.

STEP 2

Receive monitored treatment

Ketamine is given in a controlled medical setting with monitoring. Patients should not drive themselves home after treatment.

STEP 3

Track what changes

We follow mood, function, side effects and durability of benefit. Treatment frequency and next steps depend on the individual response.

What improvement may look like

What patients are usually hoping to improve.

Some patients with treatment-resistant depression experience meaningful symptom relief faster than they did with standard antidepressants, but response is not guaranteed and benefits may not last without ongoing care.

Mood may improve faster

Research has shown rapid antidepressant effects in some people with treatment-resistant depression.

Daily function may become easier

When symptoms improve, patients may find it easier to engage with relationships, work, therapy and normal routines.

A window for psychotherapy

For some patients, symptom relief can create an opportunity to participate more fully in psychotherapy and other treatments.

A monitored next step

If ketamine is not helping enough—or side effects outweigh benefits—the treatment plan should change rather than continue automatically.

Important

Ketamine can cause side effects and has misuse potential. It should be delivered only with appropriate screening, dosing, monitoring and follow-up. It is not a guaranteed or first-line treatment for depression.

Common questions

Know what you are considering.

Is ketamine the same as a normal antidepressant?

No. It acts through different brain pathways and may work more quickly in some patients, especially in treatment-resistant depression.

Is IV ketamine FDA-approved for depression?

No. IV ketamine is FDA-approved as an anesthetic; its use for depression is off-label. Esketamine, a related medication, is FDA-approved for certain depressive disorders in supervised settings.

Will one treatment fix depression?

No treatment should be presented that way. Some people respond quickly, but the number of treatments, durability of benefit and need for other therapy vary.

Start with a conversation

You do not need to know the diagnosis before you call.

Tell us what you are experiencing. The first step is deciding whether this service fits your situation and what evaluation is appropriate.

Request a consultation →